1. 37LBA Telotristat etiprate is effective in treating patients with carcinoid syndrome that is inadequately controlled by somatostatin analog therapy (the phase 3 TELESTAR clinical trial). (September 2015) Authors: Kulke, M.H.; Horsch, D.; Caplin, M.; Anthony, L.; Bergsland, E.; Oberg, K.; Welin, S.; Warner, R.; Lombard-Bohas, C.; Kunz, P.; Grande, E.; Valle, J.; Fleming, D.; Lapuerta, P.; Banks, P.; Jackson, S.; Wheeler, D.; Zambrowicz, B.; Sands, A.; Pavel, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A computational and experimental investigation of deep-blue light-emitting tetraaryl-benzobis[1, 2-d:4, 5-d′]oxazoles. Issue 9 (8th March 2022) Authors: Wheeler, D.; Tannir, S.; Smith, E.; Tomlinson, A.; Jeffries-EL, M. Journal: Materials advances Issue: Volume 3:Issue 9(2022) Page Start: 3842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A National Assessment of the Potential Linkage between Soil, and Surface and Groundwater Concentrations of Phosphorus1. (14th July 2015) Authors: McDowell, R.W.; Cox, N.; Daughney, C.J.; Wheeler, D.; Moreau, M. Journal: Journal of the American Water Resources Association Issue: Volume 51:Number 4(2015) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab. (December 2016) Authors: Iida, M.; Bahrar, H.; Brand, T.; Pearson, H.; Coan, J.; Orbuch, R.; Flanigan, B.; Swick, A.; Prabakaran, P.; Lantto, J.; Horak, I.; Kragh, M.; Salgia, R.; Kimple, R.; Wheeler, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗